Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 08 Jun 2021

Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR

in Respiratory Pharmacology

Jie Wang
Yan Ren
Xiufen Zheng
Jiaqi Kang
Zhenqian Huang
Lizhi Xu
Yaping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.675907

3,592 views
10 citations

Review

Published on 07 Jun 2021

Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential

in Respiratory Pharmacology

Xinyu Cui
Wuyue Chen
Haoyan Zhou
Yuan Gong
Bowen Zhu
Xiang Lv
Hongbo Guo
Jinao Duan
Jing Zhou
Edyta Marcon

Frontiers in Pharmacology

doi 10.3389/fphar.2021.664349

73,829 views
54 citations

Original Research

Published on 28 May 2021

Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension

in Respiratory Pharmacology

Alexandre Todorovic Fabro
Juliana Machado-Rugolo
Camila Machado Baldavira
Tabatha Gutierrez Prieto
Cecília Farhat
Flavia Regina Rotea ManGone
Sabrina Setembre Batah
Heloísa Resende Cruvinel
Maiara Almeida Aldá
Jhonatas Sirino Monteiro

Frontiers in Pharmacology

doi 10.3389/fphar.2021.648769

5,406 views
12 citations

Original Research

Published on 14 May 2021

Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells

in Respiratory Pharmacology

Zsolt Bene
Zsolt Fejes
Tibor Gabor Szanto
Ferenc Fenyvesi
Judit Váradi
Luka A. Clarke
Gyorgy Panyi
Milan Macek
Margarida D. Amaral
István Balogh

Frontiers in Pharmacology

doi 10.3389/fphar.2021.592184

3,734 views
10 citations

Original Research

Published on 04 May 2021

The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome

in Respiratory Pharmacology

Pamela Nithzi Bricher Choque
Rodolfo P. Vieira
Luis Ulloa
Caren Grabulosa
Maria Claudia Irigoyen
Katia De Angelis
Ana Paula Ligeiro De Oliveira
Kevin J. Tracey
Valentin A. Pavlov
Fernanda Marciano Consolim-Colombo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.624895

7,440 views
11 citations

Review

Published on 30 Apr 2021

Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation

in Respiratory Pharmacology

Ming Cai
Xuan Chen
Jieling Shan
Ruoyu Yang
Qi Guo
Xia Bi
Ping Xu
Xiangrong Shi
Lixi Chu
Liyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.643619

11,718 views
14 citations

Review

Published on 27 Apr 2021

Intensive Care and Treatment of Severe Guillain–Barré Syndrome

in Respiratory Pharmacology

Pei Shang
Jiachun Feng
Wei Wu
Hong-Liang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.608130

70,956 views
45 citations

Review

Published on 27 Apr 2021

On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis

in Respiratory Pharmacology

Marjolein Ensinck
Angélique Mottais
Claire Detry
Teresinha Leal
Marianne S. Carlon

Frontiers in Pharmacology

doi 10.3389/fphar.2021.662110

16,984 views
20 citations

Original Research

Published on 26 Apr 2021

Knockout of Formyl Peptide Receptor-1 Attenuates Cigarette Smoke–Induced Airway Inflammation in Mice

in Respiratory Pharmacology

Lijuan Gao
Ni Zeng
Zhicheng Yuan
Tao Wang
Lei Chen
Deqing Yang
Dan Xu
Chun Wan
Fuqiang Wen
Yongchun Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.632225

2,744 views
10 citations

Original Research

Published on 26 Apr 2021

Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy

in Respiratory Pharmacology

Alexandra McCarron
Nigel Farrow
Patricia Cmielewski
Emma Knight
Martin Donnelley
David Parsons

Frontiers in Pharmacology

doi 10.3389/fphar.2021.669635

3,177 views
6 citations

Original Research

Published on 23 Apr 2021

The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis

in Respiratory Pharmacology

Tingting Shu
Huaqiao Chen
Lu Wang
Wuwan Wang
Panpan Feng
Rui Xiang
Li Wen
Wei Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.668902

5,106 views
4 citations

Original Research

Published on 23 Apr 2021

Leflunomide Induces Dose-Dependent Lung Injury in Mice via Stimulating Vimentin and NLRP3 Inflammasome Production

in Respiratory Pharmacology

Mohamed El-Sherbiny
Hoda Atef
Mohamed Ahmed Eladl
Abdelaty Shawky Mohamed
Mohamed El-Shafey
Howaida S. Ali
Sawsan A. Zaitone
Suliman Y. Alomar
Saeed Awad M. Alqahtani
Sheka Yagub Aloyouni

Frontiers in Pharmacology

doi 10.3389/fphar.2021.631216

4,875 views
6 citations

Mini Review

Published on 23 Apr 2021

Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives

in Respiratory Pharmacology

Hayder M. Al-kuraishy
Ali I. Al-Gareeb
Mohammed Alqarni
Natália Cruz-Martins
Gaber El-Saber Batiha

Frontiers in Pharmacology

doi 10.3389/fphar.2021.642822

8,590 views
46 citations

Perspective

Published on 21 Apr 2021

Gene Therapy: A Possible Alternative to CFTR Modulators?

in Respiratory Pharmacology

J. Mercier
M. Ruffin
H. Corvol
L. Guillot

Frontiers in Pharmacology

doi 10.3389/fphar.2021.648203

14,391 views
7 citations

Perspective

Published on 20 Apr 2021

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

in Respiratory Pharmacology

Vikas P. Sukhatme
Angela M. Reiersen
Sharat J. Vayttaden
Vidula V. Sukhatme

Frontiers in Pharmacology

doi 10.3389/fphar.2021.652688

135,433 views
159 citations

Mini Review

Published on 20 Apr 2021

Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?

in Respiratory Pharmacology

Andressa Daronco Cereta
Vinícius Rosa Oliveira
Ivan Peres Costa
João Pedro Ribeiro Afonso
Adriano Luís Fonseca
Alan Robson Trigueiro de Souza
Guilherme Augusto Moreira Silva
Diego A. C. P. G. Mello
Luis Vicente Franco de Oliveira
Renata Kelly da Palma

Frontiers in Pharmacology

doi 10.3389/fphar.2021.648506

5,048 views
7 citations

Navigation group

Articles

Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR

Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential

Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension

Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells

The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome

Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation

Intensive Care and Treatment of Severe Guillain–Barré Syndrome

On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis

Knockout of Formyl Peptide Receptor-1 Attenuates Cigarette Smoke–Induced Airway Inflammation in Mice

Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy

The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis

Leflunomide Induces Dose-Dependent Lung Injury in Mice via Stimulating Vimentin and NLRP3 Inflammasome Production

Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives

Gene Therapy: A Possible Alternative to CFTR Modulators?

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?